Dietary blueberry and bifidobacteria attenuate nonalcoholic fatty liver disease in rats by affecting SIRT1-mediated signaling pathway

Oxidative Medicine and Cellular Longevity

Volumn 2014, Issue , 2014, Pages

  Ren, Tingting ^a   Huang, Chao ^a   Cheng, Mingliang ^a  

^a GUIZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA; RATS;

ANTIOXIDATIVE; BIFIDOBACTERIA; BIOCHEMICAL INDICES; CONTROL GROUPS; LIPID ACCUMULATIONS; MEDIATED SIGNALING PATHWAYS; NON-ALCOHOLIC FATTY LIVER DISEASE; SIGNALING PATHWAYS;

PLANTS (BOTANY);

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BLUEBERRY EXTRACT; GLUTATHIONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROBIOTIC AGENT; SIRTUIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; SIRT1 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BIFIDOBACTERIACEAE; BIOACCUMULATION; BLUEBERRY; CONTROLLED STUDY; DRUG MECHANISM; LIVER PROTECTION; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; RAT; RNA INTERFERENCE; SIGNAL TRANSDUCTION; ANIMAL; BEVERAGE; BIFIDOBACTERIUM; DIET THERAPY; DISEASE MODEL; FRUIT; LIPID DIET; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY; RISK FACTOR; SPRAGUE DAWLEY RAT;

RATTUS; VACCINIUM;

ANIMALS; BEVERAGES; BIFIDOBACTERIUM; BLUEBERRY PLANT; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; FRUIT; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; RISK FACTORS; SIGNAL TRANSDUCTION; SIRTUIN 1;

EID: 84916196218     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2014/469059     Document Type: Article

References (80)

1. Shen L., Fan J.-G., Shao Y., Zeng M.-D., Wang J.-R., Luo G.-H., Li J.-Q., Chen S.-Y., Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey. World Journal of Gastroenterology 2003 9 5 1106 1110 2-s2.0-0038544021
2. Cigremis Y., Turel H., Adiguzelet K., The effects of acute acetaminophen toxicity on hepatic mRNA expression of SOD, CAT, GSH-Px, and levels of peroxynitrite, nitric oxide, reduced glutathione, and malondialdehyde in rabbit. Molecular and Cellular Biochemistry 2009 323 1-2 31 38 10.1007/s11010-008-9961-8
3. Engelmann G., Hoffmann G. F., Grulich-Henn J., Teufel U., Alanine aminotransferase elevation in obese infants and children: a marker of early onset non alcoholic fatty liver disease. Hepatitis Monthly 2014 14 4 e14112 10.5812/hepatmon.14112 2-s2.0-84898881237
4. Sert A., Pirgon Ö., Aypar E., Yilmaz H., Dündar B., Relationship between aspartate aminotransferase to-platelet ratio index and carotid intima-media thickness in obese adolescents with non-alcoholic fatty liver disease. Journal of Clinical Research in Pediatric Endocrinology 2013 5 3 182 188 10.4274/Jcrpe.891 2-s2.0-84884230267
5. Fabbrini E., Mohammed B. S., Korenblat K. M., Magkos F., McCrea J., Patterson B. W., Klein S., Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease. Journal of Clinical Endocrinology and Metabolism 2010 95 6 2727 2735 2-s2.0-77954519409 10.1210/jc.2009-2622
6. Chan D. C., Watts G. F., Gan S., Wong A. T. Y., Ooi E. M. M., Barrett P. H. R., Nonalcoholic fatty liver disease as the transducer of hepatic oversecretion of very-low-density lipoprotein-apolipoprotein B-100 in Obesity. Arteriosclerosis, Thrombosis, and Vascular Biology 2010 30 5 1043 1050 2-s2.0-77951456827 10.1161/ATVBAHA.109.202275
7. Pacifico L., Bonci E., Andreoliet G., Association of serum triglyceride-to-HDL cholesterol ratio with carotid artery intima-media thickness, insulin resistance and nonalcoholic fatty liver disease in children and adolescents. Nutrition, Metabolism and Cardiovascular Diseases 2014 24 7 737 743
8. Nobili V., Donati B., Panera N., Vongsakulyanon A., Alisi A., Dallapiccola B., Valenti L., A 4-polymorphism risk score predicts steatohepatitis in children with nonalcoholic fatty liver disease. Journal of Pediatric Gastroenterology and Nutrition 2014 58 5 632 636 10.1097/MPG.0000000000000279 2-s2.0-84900417152
9. Qiang M., Xu Y., Lu Y., He Y., Han C., Liu Y., He R., Autofluorescence of MDA-modified proteins as an in vitro and in vivo probe in oxidative stress analysis. Protein and Cell 2014 5 6 484 487 2-s2.0-84901335062 10.1007/s13238-014-0052-1
10. Sayed A. A. R., Ferulsinaic acid modulates SOD, GSH, and antioxidant enzymes in diabetic kidney. Evidence-based Complementary and Alternative Medicine 2012 2012 9 580104 10.1155/2012/580104 2-s2.0-84867028242
11. Suzuki M., Takeuchi H., Kakita T., Unno M., Katayose Y., Matsuno S., The involvement of the intracellular superoxide production system in hepatic ischemia-reperfusion injuryIn vivo and in vitro experiments using transgenic mice manifesting excessive CuZn-SOD activity. Free Radical Biology and Medicine 2000 29 8 756 763 10.1016/S0891-5849(00)00369-5 2-s2.0-0034667719
12. Kotosai M., Shimada S., Kanda M., Matsuda N., Sekido K., Shimizu Y., Tokumura A., Nakamura T., Murota K., Kawai Y., Terao J., Plasma HDL reduces nonesterified fatty acid hydroperoxides originating from oxidized LDL: a mechanism for its antioxidant ability. Lipids 2013 48 6 569 578 10.1007/s11745-013-3779-1 2-s2.0-84878563314
13. Doycheva I., Loomba R., Effect of metformin on ballooning degeneration in nonalcoholic steatohepatitis (NASH): when to use metformin in nonalcoholic fatty liver disease (NAFLD). Advances in Therapy 2014 31 1 30 43 10.1007/s12325-013-0084-6 2-s2.0-84895068880
14. Riche D. M., Fleming J. W., Malinowski S. S., Black C. A., Miller K. H., Wofford M. R., Resistant nonalcoholic fatty liver disease amelioration with rosuvastatin and pioglitazone combination therapy in a patient with metabolic syndrome. Annals of Pharmacotherapy 2014 48 1 137 141 2-s2.0-84892880355 10.1177/1060028013507239
15. Zhang F., Xiang H., Fan Y., Ganchuluun T.-A., Kong W., Ouyang Q., Sun J., Cao B., Jiang H., Nie S., The effects of sulfonylureas plus metformin on lipids, blood pressure, and adverse events in type 2 diabetes: a meta-analysis of randomized controlled trials. Endocrine 2012 44 3 648 658 10.1007/s12020-013-9970-6 2-s2.0-84890796237
16. Dodiya H., Kale V., Goswami S., Sundar R., Jain M., Evaluation of adverse effects of lisinopril and rosuvastatin on hematological and biochemical analytes in wistar rats. Toxicology International 2013 20 2 170 176 2-s2.0-84884564757 10.4103/0971-6580.117261
17. Valenti L., Riso P., Mazzocchi A., Porrini M., Fargion S., Agostoni C., Dietary anthocyanins as nutritional therapy for nonalcoholic fatty liver disease. Oxidative Medicine and Cellular Longevity 2013 2013 8 145421 10.1155/2013/145421 2-s2.0-84887434533
18. Bornsek S. M., Ziberna L., Polak T., Bilberry and blueberry anthocyanins act as powerful intracellular antioxidants in mammalian cells. Food Chemistry 2012 134 4 1878 1884 10.1016/j.foodchem.2012.03.092 2-s2.0-84861576692
19. Li X., Sun H., Pei J., Dong Y., Wang F., Chen H., Sun Y., Wang N., Li H., Li Y., De novo sequencing and comparative analysis of the blueberry transcriptome to discover putative genes related to antioxidants. Gene 2012 511 1 54 61 10.1016/j.gene.2012.09.021 2-s2.0-84867642501
20. Wang Y., Cheng M., Zhang B., Nie F., Jiang H., Dietary supplementation of blueberry juice enhances hepatic expression of metallothionein and attenuates liver fibrosis in rats. PLoS ONE 2013 8 3 e58659 10.1371/journal.pone.0058659 2-s2.0-84874912882
21. Chang O. K., Seol K.-H., Jeong S.-G., Oh M.-H., Park B.-Y., Perrin C., Ham J.-S., Casein hydrolysis by Bifidobacterium longum KACC91563 and antioxidant activities of peptides derived therefrom. Journal of Dairy Science 2013 96 9 5544 5555 2-s2.0-84882833723 10.3168/jds.2013-6687
22. Shen Q., Shang N., Li P., In vitro and in vivo antioxidant activity of bifidobacterium animalis 01 isolated from centenarians. Current Microbiology 2011 62 4 1097 1103 10.1007/s00284-010-9827-7 2-s2.0-79954422661
23. Osman N., Adawi D., Ahrné S., Jeppsson B., Molin G., Endotoxin- and D-galactosamine-induced liver injury improved by the administration of Lactobacillus, Bifidobacterium and blueberry. Digestive and Liver Disease 2007 39 9 849 856 10.1016/j.dld.2007.06.001 2-s2.0-34547657678
24. Colak Y., Yesil A., Mutluet H. H., A potential treatment of non-alcoholic fatty liver disease with SIRT1 activators. Journal of Gastrointestinal and Liver Diseases 2014 23 3 311 319 10.15403/jgld.2014.1121.233.yck
25. Gillum M. P., Erion D. M., Shulman G. I., Sirtuin-1 regulation of mammalian metabolism. Trends in Molecular Medicine 2011 17 1 8 13 2-s2.0-78650987216 10.1016/j.molmed.2010.09.005
26. Purushotham A., Schug T. T., Xu Q., Surapureddi S., Guo X., Li X., Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metabolism 2009 9 4 327 338 10.1016/j.cmet.2009.02.006 2-s2.0-63449112017
27. Deplanque D., Gelé P., Pétrault O., Six I., Furman C., Bouly M., Nion S., Dupuis B., Leys D., Fruchart J.-C., Cecchelli R., Staels B., Duriez P., Bordet R., Peroxisome proliferator-activated receptor- α activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment. Journal of Neuroscience 2003 23 15 6264 6271 2-s2.0-0038720453
28. Sun W. M., Wang Y. P., Duan Y. Q., Radix Hedysari polysaccharide suppresses lipid metabolism dysfunction in a rat model of nonalcoholic fatty liver disease via adenosine monophosphateactivated protein kinase pathway activation. Molecular Medicine Reports 2014 10 3 1237 1244
29. Lamoureux L., Roy D., Gauthier S. F., Production of oligosaccharides in yogurt containing bifidobacteria and yogurt cultures. Journal of Dairy Science 2002 85 5 1058 1069 2-s2.0-0036562511 10.3168/jds.S0022-0302(02)74166-0
30. Cano A., Ciaffoni F., Safwat G. M., Hepatic VLDL assembly is disturbed in a rat model of nonalcoholic fatty liver disease: is there a role for dietary coenzyme Q? Journal of Applied Physiology 2009 107 3 707 717 10.1152/japplphysiol.00297.2009 2-s2.0-69749097150
31. Hunt G. B., Luff J. A., Daniel L., Bergh R. V. D., Evaluation of hepatic steatosis in dogs with congenital portosystemic shunts using oil red o staining. Veterinary Pathology 2013 50 6 1109 1115 10.1177/0300985813481609 2-s2.0-84887545584
32. Wang Y., Goulart R. A., Pantanowitz L., Oil red O staining in cytopathology. Diagnostic Cytopathology 2011 39 4 272 273 10.1002/dc.21390 2-s2.0-79952792686
33. Feldman A. T., Wolfe D., Tissue processing and hematoxylin and eosin staining. Histopathology 2014 1180 New York, NY, USA Springer 31 43 Methods in Molecular Biology 10.1007/978-1-4939-1050-2-3
34. Murakami K., Takahashi R., Ono M., Watanabe K., Okimoto T., Kodama M., Abe D., Kimura M., Fujioka T., Serodiagnosis of Helicobacter hepaticus infection in patients with liver and gastrointestinal diseases: western blot analysis and ELISA using a highly specific monoclonal antibody for H. hepaticus antigen. Journal of Gastroenterology 2011 46 9 1120 1126 10.1007/s00535-011-0414-x 2-s2.0-80755140117
35. Jelenik T., Floegel U., Phielixet E., Non-alcoholic fatty liver disease and insulin resistance are associated with increased cardiac oxidative stress in mice. European Heart Journal 2013 34 931 932
36. Dong X., Li D., Liu H., Zhao Y. Y., SOD3 and eNOS genotypes are associated with SOD activity and NOx. Experimental and Therapeutic Medicine 2014 8 1 328 334 2-s2.0-84901325519 10.3892/etm.2014.1720
37. Su S., Li Q., liu Y., Xiong C., Li J., Zhang R., Niu Y., Zhao L., Wang Y., Guo H., Sesamin ameliorates doxorubicin-induced cardiotoxicity: Involvement of Sirt1 and Mn-SOD pathway. Toxicology Letters 2014 224 2 257 263 10.1016/j.toxlet.2013.10.034 2-s2.0-84888418518
38. Kumar S. M., Swaminathan K., Clemens D. L., Dey A., GSH protects against oxidative stress and toxicity in VL-17A cells exposed to high glucose. European Journal of Nutrition 2014 10.1007/s00394-014-0703-2 2-s2.0-84901581548
39. Jung S., Kim O. Y., Kim M., Song J., Lee S. H., Lee J. H., Age-related increase in alanine aminotransferase correlates with elevated levels of plasma amino acids, decanoylcarnitine, Lp-PLA2 activity, oxidative stress, and arterial stiffness. Journal of Proteome Research 2014 13 7 3467 3475 10.1021/pr500422z
40. Yamada J., Tomiyama H., Yambeet M., Elevated serum alanine aminotransferase is a marker of inflammation and oxidative stress associated with the metabolic syndrome. Journal of Hypertension 2006 24 193
41. Mansour H. H., Nel S. I., Hafez H. F., Ameliorative effect of septilin, an ayurvedic preparation against γ -irradiation-induced oxidative stress and tissue injury in rats. Indian Journal of Biochemistry and Biophysics 2014 51 2 135 141 2-s2.0-84899672901
42. Paoletti F., Mocali A., Determination of superoxide dismutase activity by purely chemical system based on NAD(P)H oxidation. Methods in Enzymology 1990 186 209 220 10.1016/0076-6879(90)86110-H 2-s2.0-0024991845
43. Hissin P. J., Hilf R., A fluorometric method for determination of oxidized and reduced glutathione in tissues. Analytical Biochemistry 1976 74 1 214 226 10.1016/0003-2697(76)90326-2 2-s2.0-0017064979
44. Gastaldelli A., Gaggini M., Mezzabotta L., Alteration in lipid metabolism after an oral fat load in subjects with NAFLD. Diabetologia 2013 56 S323 10.1007/s00125-012-2760-5
45. Musso G., Gambino R., Cassader M., Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Progress in Lipid Research 2009 48 1 1 26 10.1016/j.plipres.2008.08.001 2-s2.0-57649214103
46. Gheita T. A., Kenawy S. A., Measurement of malondialdehyde, glutathione, and glutathione peroxidase in SLE patients. Methods in Molecular Biology 2014 1134 193 199 10.1007/978-1-4939-0326-9-14 2-s2.0-84896274990
47. Colak Y., Ozturk O., Senates E., Tuncer I., Yorulmaz E., Adali G., Doganay L., Enc F. Y., SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease. Medical Science Monitor 2011 17 5, article HY5-9 2-s2.0-79955941313
48. Ziamajidi N., Khaghani S., Hassanzadehet G., Amelioration by chicory seed extract of diabetes- and oleic acid-induced non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) via modulation of PPARalpha and SREBP-1. Food and Chemical Toxicology 2013 58 198 209
49. Feldstein A. E., Papouchado B. G., Angulo P., Sanderson S., Adams L., Gores G. J., Hepatic stellate cells and fibrosis progression in patients with nonalcoholic fatty liver disease. Clinical Gastroenterology and Hepatology 2005 3 4 384 389 10.1016/S1542-3565(04)00616-0 2-s2.0-16844380835
50. Sumida Y., Niki E., Naito Y., Yoshikawa T., Involvement of free radicals and oxidative stress in NAFLD/NASH. Free Radical Research 2013 47 11 869 880 10.3109/10715762.2013.837577 2-s2.0-84885945197
51. Podrini C., Borghesan M., Greco A., Pazienza V., Mazzoccoli G., Vinciguerra M., Redox homeostasis and epigenetics in non-alcoholic fatty liver disease (NAFLD). Current Pharmaceutical Design 2013 19 15 2737 2746 10.2174/1381612811319150009 2-s2.0-84876727580
52. Alkassabany Y. M., Farghaly A. G., El-Ghitany E. M., Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt. Arab Journal of Gastroenterology 2014 15 2 76 81 10.1016/j.ajg.2014.05.002
53. Kalra S., Vithalani M., Gulati G., Kulkarni C. M., Kadam Y., Pallivathukkal J., Das B., Sahay R., Modi K. D., Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT). Journal of Association of Physicians of India 2013 61 7 448 453 2-s2.0-84880024479
54. Malespin M., Sleesman B., Lau A., Wong S. S., Cotler S. J., Prevalence and correlates of suspected nonalcoholic fatty liver disease in Chinese American children. Journal of Clinical Gastroenterology 2014 2-s2.0-84896551147 10.1097/MCG.0000000000000121
55. López-Velázquez J. A., Silva-Vidal K. V., Ponciano-Rodríguez G., Chávez-Tapia N. C., Arrese M., Uribe M., Méndez-Sánchez N., The prevalence of nonalcoholic fatty liver disease in the Americas. Annals of Hepatology 2014 13 2 166 178 2-s2.0-84893696694
56. Watts G. F., Nutrition and metabolism: nutritional therapy for disordered triglyceride metabolism and nonalcoholic fatty liver disease. Current Opinion in Lipidology 2010 21 6 545 547 10.1097/MOL.0b013e3283404fb5 2-s2.0-78649343879
57. Andrews D. B., Lavine J. E., Medical therapy for nonalcoholic fatty liver disease in children and adolescents. Expert Review of Gastroenterology and Hepatology 2012 6 1 1 3 2-s2.0-83455236263 10.1586/egh.11.72
58. Eckard C., Cole R., Lockwood J., Torres D. M., Williams C. D., Shaw J. C., Harrison S. A., Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trial. Therapeutic Advances in Gastroenterology 2013 6 4 249 259 10.1177/1756283X13484078 2-s2.0-84878330831
59. Tock L., Dâmaso A. R., de Piano A., Carnier J., Sanches P. L., Lederman H. M., Ernandes R. M. Y., De Mello M. T., Tufik S., Long-term effects of metformin and lifestyle modification on nonalcoholic fatty liver disease obese adolescents. Journal of Obesity 2010 2010 6 831901 10.1155/2010/831901 2-s2.0-79953254022
60. Smith R. C., Metformin as a treatment for antipsychotic drug side effects: special focus on women with schizophrenia. The American Journal of Psychiatry 2012 169 8 774 776 10.1176/appi.ajp.2012.12050591 2-s2.0-84864807644
61. Marhamatizadeh M. H., Ehsandoost E., Gholami P., Nazemi M., Effect of Denak (Oliverici decumbens Vent) on growth and survival of Lactobacillus acidophilus and Bifidobacterium bifidum for production of probiotic herbal milk and yoghurt. Pakistan Journal of Biological Sciences 2013 16 24 2009 2014 10.3923/pjbs.2013.2009.2014 2-s2.0-84883857620
62. Bellavia M., Rappa F., Lo Belloet M., Lactobacillus casei and bifidobacterium lactis supplementation reduces tissue damage of intestinal mucosa and liver after 2,4,6-trinitrobenzenesulfonic acid treatment in mice. Journal of Biological Regulators and Homeostatic Agents 2014 28 2 251 261
63. Bingül I., Başaran-Küçükgergin C., Tekkeşin M. S., Olgaç V., Doʇru-Abbasoʇlu S., Uysal M., Effect of blueberry pretreatment on diethylnitrosamine-induced oxidative stress and liver injury in rats. Environmental Toxicology and Pharmacology 2013 36 2 529 538 10.1016/j.etap.2013.05.014
64. Jeon B. T., Heo R. W., Shin H. J., Attenuation by a Vigna nakashimae extract of nonalcoholic fatty liver disease in high-fat diet-fed mice. Bioscience, Biotechnology, and Biochemistry 2014 78 3 482 489 10.1080/09168451.2014.882753
65. Liu J., Zhuang Z. J., Bian D. X., Toll-like receptor-4 signalling in the progression of non-alcoholic fatty liver disease induced by high-fat and high-fructose diet in mice. Clinical and Experimental Pharmacology and Physiology 2014 41 7 482 488
66. Dai Y., Faller D. V., Transcription regulation by class III histone deacetylases (HDACs)-sirtuins. Translational Oncogenomics 2008 2008 3 53 65 2-s2.0-77953417440
67. Colak Y., Ozturk O., Senates E., Tuncer I., Yorulmaz E., Adali G., Doganay L., Enc F. Y., SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease. Medical Science Monitor 2011 17 5 Hy5 Hy9 2-s2.0-79955941313
68. Wang Y. P., Cheng M. L., Zhang B. F., Mu M., Zhou M. Y., Wu J., Li C. X., Effect of blueberry on hepatic and immunological functions in mice. Hepatobiliary and Pancreatic Diseases International 2010 9 2 164 168 2-s2.0-77951860160
69. Yang Y., Li W., Liu Y., Alpha-lipoic acid improves high-fat diet-induced hepatic steatosis by modulating the transcription factors SREBP-1, FoxO1 and Nrf2 via the SIRT1/LKB1/AMPK pathway. The Journal of Nutritional Biochemistry 2014 25 11 1207 1217 10.1016/j.jnutbio.2014.06.001
70. Xu M., Wang B., Fu Y., Chen Y., Yang F., Lu H., Xu J., Li L., Changes of fecal Bifidobacterium species in adult patients with hepatitis B virus-induced chronic liver disease. Microbial Ecology 2012 63 2 304 313 10.1007/s00248-011-9925-5 2-s2.0-84856733664
71. Ponugoti B., Kim D. H., Xiao Z., Smith Z., Miao J., Zang M., Wu S. Y., Chiang C. M., Veenstra T. D., Kemper J. K., SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism. Journal of Biological Chemistry 2010 285 44 33959 33970 2-s2.0-77958595135 10.1074/jbc.M110.122978
72. Wang L., Teng R., Di L., Rogers H., Wu H., Kopp J. B., Noguchi C. T., PPARa and sirt1 mediate erythropoietin action in increasing metabolic activity and browning of white adipocytes to protect against obesity and metabolic disorders. Diabetes 2013 62 12 4122 4131 10.2337/db13-0518 2-s2.0-84891800733
73. Correa-Betanzo J., Allen-Vercoe E., McDonald J., Schroeter K., Corredig M., Paliyath G., Stability and biological activity of wild blueberry (Vaccinium angustifolium) polyphenols during simulated in vitro gastrointestinal digestion. Food Chemistry 2014 165 522 531 10.1016/j.foodchem.2014.05.135
74. Ozcelik E., Uslu S., Burukoglu D., Chitosan and blueberry treatment induces arginase activity and inhibits nitric oxide production during acetaminophen-induced hepatotoxicity. Pharmacognosy Magazine 2014 10 supplement 2 S217 S224
75. Zhao Y., Ling F., Griffin T. M., Up-regulation of the Sirtuin 1 (Sirt1) and Peroxisome Proliferator-activated Receptor γ Coactivator-1 α (PGC-1 α) Genes in White Adipose Tissue of Id1 Protein-deficient Mice: IMPLICATIONS IN THE PROTECTION AGAINST DIET AND AGE-INDUCED GLUCOSE INTOLERANCE. The Journal of Biological Chemistry 2014 289 42 29112 29122
76. Feillet-Coudray C., Aoun M., Fouret G., Bonafos B., Ramos J., Casas F., Cristol J. P., Coudray C., Effects of long-term administration of saturated and n-3 fatty acid-rich diets on lipid utilisation and oxidative stress in rat liver and muscle tissues. British Journal of Nutrition 2013 110 10 1789 1802 10.1017/S0007114513001311 2-s2.0-84887218348
77. Khanal R. C., Howard L. R., Brownmiller C. R., Prior R. L., Influence of extrusion processing on procyanidin composition and total anthocyanin contents of blueberry pomace. Journal of Food Science 2009 74 2 H52 H58 10.1111/j.1750-3841.2009.01063.x 2-s2.0-62549091424
78. Li S., Chen L., Yang T., Wu Q., Lv Z., Xie B., Sun Z., Increasing antioxidant activity of procyanidin extracts from the pericarp of Litchi chinensis processing waste by two probiotic bacteria bioconversions. Journal of Agricultural and Food Chemistry 2013 61 10 2506 2512 10.1021/jf305213e 2-s2.0-84874982757
79. Zhong J., Cong H., Inhibition of grape procyanidin on the expression of SSTR-2 mRNA in the hepatic cells induced by N-nitroso compounds. Wei Sheng Yan Jiu 2004 33 4 430 432 2-s2.0-33746385088
80. Plantinga T. S., Van Maren W. W. C., Van Bergenhenegouwen J., ETAL, Differential toll-like receptor recognition and induction of cytokine profile by Bifidobacterium breve and Lactobacillus strains of probiotics. Clinical and Vaccine Immunology 2011 18 4 621 628 10.1128/CVI.00498-10 2-s2.0-79954562343